Pre-Exposure Prophylaxis to Prevent HIV
common.study.values.description
“IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project”
The overall aim of this study is to assess attitudes toward PrEP, feasibility of Truvada PrEP procurement through the established access procedures, and adherence to Truvada PrEP among US women at risk for HIV acquisition.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - tenofovir disoproxil and emtricitabine
Pre-exposure Prophylaxis with Truvada will be distributed to all participants eligible to receive PrEP.
participant.views.study.view.additional
participant.views.study.view.scientific-title
IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project
common.study.values.clinical-trial-id
NCT03058835
participant.views.study.view.id
qaQGLd
